CD9 and infection: Supernatants were tested for reactivity to full-length BA.2 S or BA.2 RBD; in common with the panel of mAbs generated following Omicron BA.1 infection,13 a high proportion (67%) of mAbs recognized the BA.2 RBD (Figure 2B).